Skip to main content

Find Clinical Trials

Home
Conditions
Relapse or Refractory Myeloid Malignancies

Clinical trial condition

Relapse or Refractory Myeloid Malignancies

Explore clinical trials studying Relapse or Refractory Myeloid Malignancies. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Relapse or Refractory Myeloid Malignancies trial results

Not yet recruiting

A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma.

NCT07779798

Conditions: Advanced Solid Tumors, Disease Attributes, Pathologic Processes, +4 more
Locations: NEXT Oncology- Virginia Fairfax, Virginia, United States

View Trial Details